Are n-3 polyunsaturated fatty acids antiarrhythmic in the absence of ischemia? Editorial to: "The role of n-3 PUFAs in preventing the arrhythmic risk in patients with idiopathic dilated cardiomyopathy" by S. Nodari et al.
Raitt
Meritt H
MH
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D009202:Cardiomyopathies / Q000150:complications / Q000503:physiopathology; D002986:Clinical Trials as Topic; D015525:Fatty Acids, Omega-3 / Q000494:pharmacology*; D006801:Humans; D017202:Myocardial Ischemia / Q000150:complications / Q000503:physiopathology; D012307:Risk Factors
D000889:Anti-Arrhythmia Agents; D015525:Fatty Acids, Omega-3